Skip to content

Preoperative ROX Index and Postoperative Hypoxemia in Bariatric Surgery

Predictive Value of the Preoperative ROX Index for Early Postoperative Hypoxemia in Bariatric Surgery Patients: A Prospective Observational Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07303205
Enrollment
80
Registered
2025-12-24
Start date
2025-12-25
Completion date
2026-03-01
Last updated
2025-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia

Brief summary

This prospective observational study evaluates whether the preoperative ROX index can predict early postoperative hypoxemia in patients undergoing bariatric surgery. Preoperative ROX measurements, along with ARISCAT and STOP-Bang scores, will be assessed for their association with hypoxemia occurring within the first 12 postoperative hours.

Interventions

OTHERPreoperative ROX Index Assessment

Participants will undergo a preoperative assessment including measurement of the ROX index (SpO₂/FiO₂ divided by respiratory rate) before bariatric surgery. No treatment or study-related intervention will be applied; all perioperative care will follow routine clinical practice.

Sponsors

Istinye University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-65 years * Scheduled for elective bariatric surgery (laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass) * Body mass index (BMI) ≥ 35 kg/m² * ASA physical status I-III * Able and willing to provide written informed consent

Exclusion criteria

* Acute respiratory failure, pneumonia, or active pulmonary infection * Receiving oxygen therapy or respiratory support (nasal cannula, CPAP, BiPAP, or high-flow oxygen) preoperatively * Preoperative SpO₂ \< 88% on room air * Significant cardiac arrhythmia, severe heart failure (NYHA class III-IV), or hemodynamic instability * Pregnancy, active malignancy, or current immunosuppressive therapy * Inability to complete postoperative follow-up or early discharge before 12-hour assessment

Design outcomes

Primary

MeasureTime frameDescription
Early Postoperative HypoxemiaPostoperative 0-12 hoursHypoxemia defined as SpO₂ \< 92% or new oxygen requirement within the first postoperative hours.

Countries

Turkey (Türkiye)

Contacts

Primary Contactilke dolgun
ilkeser2004@gmail.com+905555485632

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026